Marriott International Inc. has selected downtown Bethesda as the site of its new headquarters. Exactly where is still to be determined.
The hospitality giant (NASDAQ: MAR), now the largest in the world following its merger with Starwood Hotels & Resorts Worldwide Inc., says it is still considering several Metro-accessible sites for a $600 million facility. It expects to make that selection in the first half of 2017.
On Jan. 20, 2015, about 30 minutes into his State of the Union Address, President Barack Obama said the words that would set in motion a health research initiative that could exceed the scope of any that has come before it.
Obama told listeners that he was green-lighting the launch of the Precision Medicine Initiative, a program two decades in the making that would begin where the groundbreaking Human Genome Project left off.
The Clark Charitable Foundation gifted Johns Hopkins University $15 million to provide financial aid and create a new academic program for undergraduate engineering students.
The gift honors the late A. James Clark, a former trustee of the university and of Johns Hopkins Medicine and former CEO of Clark Enterprises and Clark Construction Group LLC, one of the country’s largest privately held general building contractors. It is the largest endowed scholarship gift ever given to the university’s Whiting School of Engineering.
Today CosmosID announced participation in Vice President Biden’s National Cancer Moonshot, which aims to accelerate progress in preventing, diagnosing, and treating cancer. CosmosID will provide access to its automated bioinformatics platform, MetaGenID, for five cancer microbiome research studies (valued at $150,000) to understand how the microbiome (i.e. oral, gut, and skin) contributes to development of specific cancers.
As part of the White House’s Cancer Moonshot Initiative, today, SHARE For Cures (www.SHAREForCures.org) launched a technology platform and study aimed to gather a better understanding of the real-world use of novel cancer immunotherapy drugs.
SHARE For Cures’ new SHARE platform will easily and securely gather clinical, wellness, lifestyle, and patient-reported data about cancer immunotherapy use, side effects and benefits. Once gathered, the data will enable researchers to better understand how these new therapies are being used outside of clinical trials, as well as the health impact of specific drugs on real-world patients.
Vertex says it has updated an R&D collaboration with Cystic Fibrosis Foundation Therapeutics (CFFT) stretching back more than a decade.
Under the updated Research, Development and Commercialization Agreement, disclosed in a regulatory filing yesterday, CFFT—the Foundation’s nonprofit drug discovery and development affiliate—agreed to pay Vertex $75 million upfront, as well as up to $6 million annually toward development funding.
Facing federal and state pressure to raise retention and graduation rates, dozens of colleges and universities are developing analytics tools to help students make better decisions about everything from courses to social activities.
Purdue University has notified its 7,300 incoming freshman about a new web application that could help them better acclimate to life on campus. Administrators at the West Lafayette, Ind., school view the software as a critical tool for an institution whose graduation rate hovers at around 50 percent.
PricewaterhouseCoopers published its quarterly MoneyTree Report Friday showing that startups of all stripes garnered a total of $10.6 billion through 891 deals nationwide. However, the deal value and the number of deals fell 36 percent and 25 percent respectively from the same quarter last year.
Venture capitalists invested $19.6 million in Maryland companies in the third quarter, the lowest total in any quarter since 1997.
The total investment represents a 76 percent decrease from the second quarter and is down 86 percent from the third quarter last year, according to a MoneyTree Report from PricewaterhouseCoopers LLP and the National Venture Capital Association, based on data provided by Thomson Reuters.
MD Start, a European medical technology accelerator, announced Thursday that it has raised $11.5 million to create and fund four new French companies that can fulfill unmet needs in the medical device market.
The round was led by French Tech Acceleration Fund managed by Bpifrance, a French public investment bank. Other returning investors were French venture capital firm Sofinnova Partners, Dublin-based Medtronic, and LivaNova, a London-based medical device company.
